Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Translation01:31

Translation

14.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
14.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Regulated mRNA Transport02:22

Regulated mRNA Transport

6.2K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MedNLP-Hub: A knowledgebase platform for biomedical NLP tool discovery in clinical informatics.

International journal of medical informatics·2026
Same author

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same author

Innovative diabetes mellitus treatment strategies: Mesenchymal stem cell-based therapy and its impact on pro- and anti-inflammatory cytokines modulation.

Journal of pharmaceutical analysis·2026
Same author

Augmenting large language models with clinical knowledge graph for personalized perioperative fluid therapy question answering.

PLOS digital health·2026
Same author

Modulating the Gut-Liver Axis: Anti-Inflammatory Mechanisms of Probiotics and Prebiotics in MASLD.

Probiotics and antimicrobial proteins·2026
Same author

PEPRKD-depression: A knowledge database supporting evidence-based personalized exercise prescription recommendations in depression.

Digital health·2026

Related Experiment Video

Updated: May 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.4K

Translational Informatics Driven Drug Repositioning for Neurodegenerative Disease.

Xin Zheng1, Jing Chen2, Yuxin Zhang1

  • 1Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Current Neuropharmacology
|February 12, 2025
PubMed
Summary
This summary is machine-generated.

Drug repositioning uses artificial intelligence and big data to find new uses for existing drugs to treat neurodegenerative diseases. This approach offers faster, more cost-effective therapeutic options for patients.

Keywords:
Drug Repositioningalgorithmartificial intelligencedatabase.drug repurposingmodelneurodegenerative diseasestranslational informatics

More Related Videos

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.4K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

60.1K

Related Experiment Videos

Last Updated: May 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.4K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.4K
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

60.1K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Computational Biology
  • Translational Informatics

Background:

  • Neurodegenerative diseases are a growing public health concern due to increasing lifespans.
  • Current treatments offer only symptomatic relief, highlighting the need for novel therapeutic interventions.
  • Existing drugs lack efficacy for many neurodegenerative conditions, necessitating innovative drug discovery approaches.

Purpose of the Study:

  • To review drug repositioning strategies for neurodegenerative diseases using translational informatics.
  • To systematize data sources and computational models for drug repositioning.
  • To identify current and future computational models and databases for neurodegenerative disease drug discovery.

Main Methods:

  • Systematized drug repositioning databases and online platforms.
  • Classified computational models based on drug-drug, drug-target, and drug-disease interactions (e.g., machine learning, deep learning, network-based approaches).
  • Highlighted computational models and databases relevant to neurodegenerative disease research.

Main Results:

  • Identified and organized key data resources for drug repositioning.
  • Categorized various computational models applicable to drug repositioning.
  • Showcased current AI-driven approaches in neurodegenerative disease research.

Conclusions:

  • Drug repositioning, powered by AI and big data, is a promising strategy for developing treatments for complex neurodegenerative diseases.
  • This data-driven approach can accelerate the discovery of rapid and cost-effective therapeutic options.
  • Translational informatics provides a robust framework for advancing drug repositioning in neurodegenerative disease research.